Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-10-14, the close was $473.46: 0.5% above the 50-day average and 2.7% below the 200-day average, which is rising. RSI (14) is 54, in its neutral range. MACD is bullish. The stock sits 46% of the way up its 52-week range of $398.93 to $562.05, on 1.2x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $471.21 | Price 0.5% above |
| 200-day average | $486.71 | Price 2.7% below, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 54 | Neutral range |
| MACD (12, 26, 9) | +3.53 vs +2.17 | Line above signal |
| 52-week range | $398.93 to $562.05 | 46% of the way up the range |
| Volume vs 20-day average | 1.2x | Normal |
Base rates use HUBB's own daily history since 2015; they describe the past, not a forecast.
As of 2026-10-14, HUBB's 14-day RSI is 54, which is in the neutral range between 30 and 70.
No. HUBB closed at $473.46 on 2026-10-14, 2.7% below its 200-day average of $486.71, which is rising. When it closed below its 200-day average (528 days), it was higher 63 trading days later 88% of the time, median +13.1%.
Yes. HUBB closed at $473.46 on 2026-10-14, 0.5% above its 50-day average of $471.21. When it closed above its 50-day average (1,669 days), it was higher 63 trading days later 64% of the time, median +3.8%.
No cross in the last 10 trading days. As of 2026-10-14 the MACD line is +3.53 against a signal line of +2.17, so MACD is bullish.
No. At $473.46 it sits 46% of the way up its 52-week range of $398.93 to $562.05, 15.8% below the high.
Neutral: 2 of 5 indicators are bullish and 2 bearish as of 2026-10-14 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
HUBB analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.